Serious infections with antirheumatic therapy: are biologicals worse?
- PMID: 17038474
- PMCID: PMC1798385
- DOI: 10.1136/ard.2006.058503
Serious infections with antirheumatic therapy: are biologicals worse?
Abstract
This paper reviews the current evidence for the role of antirheumatic therapy in the development of serious infections in patients with rheumatoid arthritis (RA). Prednisone is clearly associated with increased infectious risk, but no definitive data link methotrexate to infection. Emerging data suggest that biological agents also pose increase infectious risk, particularly when used in combination with corticosteroids or methotrexate. Further research is needed in this important aspect of RA treatment. In the meantime, the author recommends that physicians should remain vigilant for serious infections in their patients with RA and use appropriate vaccines and screening procedures to mitigate their risk.
Conflict of interest statement
Competing interests: none declared
References
-
- Baum J. Infection in rheumatoid arthritis. Arthritis Rheum 197114135–137. - PubMed
-
- Mitchell W S, Brooks P M, Stevenson R D, Buchanan W W. Septic arthritis in patients with rheumatoid disease: a still underdiagnosed complication. J Rheumatol 19763124–133. - PubMed
-
- Hernandez‐Cruz B, Cardiel M H, Villa A R, Alcocer‐Varela J. Development, recurrence, and severity of infections in Mexican patients with rheumatoid arthritis: a nested case‐control study. J Rheumatol 1998251900–1907. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical